Literature DB >> 12828157

Topical treatment of persistent cutaneous leishmaniasis with ethanolic lipid amphotericin B.

Alex Zvulunov1, Emanuala Cagnano, Shoshana Frankenburg, Yehezkel Barenholz, Daniel Vardy.   

Abstract

A 1.5-year-old infant was referred because of spreading skin lesions diagnosed earlier as cutaneous leishmaniasis that did not respond to repeated courses with paromomycin-containing ointment. After consideration of the alternative therapeutic options, the infant was treated with a topical colloidal solution of amphotericin B for 3 weeks, This mode of therapy resulted in resolution of the skin lesions. No local or systemic side effects were observed. There were no signs of recurrence 3 months after cessation of the treatment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12828157

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  5 in total

1.  Efficacy of Topical Liposomal Amphotericin B versus Intralesional Meglumine Antimoniate (Glucantime) in the Treatment of Cutaneous Leishmaniasis.

Authors:  Pouran Layegh; Omid Rajabi; Mahmoud Reza Jafari; Parisa Emamgholi Tabar Malekshah; Toktam Moghiman; Hami Ashraf; Roshanak Salari
Journal:  J Parasitol Res       Date:  2011-11-24

Review 2.  Sporotrichosis: an overview and therapeutic options.

Authors:  Vikram K Mahajan
Journal:  Dermatol Res Pract       Date:  2014-12-29

3.  Effect of Topical Morphine on Cutaneous Leishmaniasis in an Animal Model: A Preliminary Report.

Authors:  Fariborz Ghaffarpasand; Afsoon Akbarzadeh; Hamid Reza Heiran; Ali Asghar Karimi; Armin Akbarzadeh; Mohamed Amin Ghobadifar
Journal:  Iran Red Crescent Med J       Date:  2016-05-11       Impact factor: 0.611

4.  Fixed cutaneous sporotrichosis treated with topical amphotericin B in an immune suppressed patient.

Authors:  Vikram K Mahajan; Karaninder S Mehta; Pushpinder S Chauhan; Mrinal Gupta; Rajni Sharma; Ritu Rawat
Journal:  Med Mycol Case Rep       Date:  2015-01-24

5.  Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis.

Authors:  Mahmoud Reza Jaafari; Mahdi Hatamipour; Seyedeh Hoda Alavizadeh; Azam Abbasi; Zahra Saberi; Sima Rafati; Yasaman Taslimi; Akram Miramin Mohammadi; Ali Khamesipour
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2019-09-23       Impact factor: 4.077

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.